Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1657, 2008-01, pp. : 4-4
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Solifenacin economically dominant in OAB
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 563, 2008-01 ,pp. :
Access to resources
Recommend
Solifenacin economically dominant in OAB
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 521, 2007-01 ,pp. :
Solifenacin effective to the core of OAB
Inpharma, Vol. 1, Iss. 1536, 2006-01 ,pp. :
Solifenacin still shining in OAB
Inpharma, Vol. 1, Iss. 1572, 2007-01 ,pp. :
Solifenacin electric for elderly with OAB: the VOLT and VERSUS data
Inpharma, Vol. 1, Iss. 1662, 2008-01 ,pp. :